C-type lectin receptor antagonists (OSE Immunotherapeutics)

N/A

Report date: 2024/10/24 17:02:22

Base Information

Drug NameC-type lectin receptor antagonists (OSE Immunotherapeutics)
Drug Alias NameCLEC-1 antagonist antibodiesCLEC-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-type lectin antagonists
TargetsC-type lectins
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOse Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOse Immunotherapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A